Why is Torrent Pharma falling/rising?

As of 04-Sep, Torrent Pharmaceuticals Ltd. is experiencing a decline in its stock price, currently at 3,592.60, which reflects a decrease of 7.45 points or 0.21%. Today's price movement indicates a trend reversal, as the stock has fallen after four consecutive days of gains. The stock's performance today is in line with the sector, but it has seen a significant drop in investor participation, with delivery volume falling by 42.77% compared to the five-day average. Despite this decline, the stock has shown strong performance over the longer term, with a year-to-date return of 7.06% and a three-year return of 136.49%, outperforming the broader market indices in these periods. Positive factors such as high management efficiency, a low debt-to-EBITDA ratio, and consistent positive results over the last eight quarters contribute to its overall stability.
In the broader market context, the stock's short-term performance over the past week shows a gain of 0.60%, which is slightly below the Sensex's gain of 0.80%. This indicates that while Torrent Pharmaceuticals has been performing well recently, it has not kept pace with the benchmark index. The high institutional holdings at 24.75% suggest that knowledgeable investors are backing the stock, which may provide some support against the recent price decline. However, the falling delivery volume and the current price drop indicate that investor sentiment may be shifting, warranting caution in the short term.